VERASTEM, INC.
Last · NASDAQ$7.71-0.54 (-6.55%)live · yahoo · 4h ago
Vol 33.74M ≈ 260.13M
MA10MA20MA50
Market cap$698.24M90.6M sh
P/E · TTM-3.1fwd -10.3 · eps -2.45 · loss
Beta0.39vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.43$10.82
Volume33.8Msession
Issuer
Legal nameVERASTEM, INC.
HQUnited States (US)
ListingUS VSTM
ISINUS92337C2035
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001526119
CIK0001526119
Websitewww.verastem.com
Employees102
AddressVerastem, Inc. 117 Kendrick Street 02494, Needham +781 292 4200
| Revenue | $30.9M |
|---|---|
| Operating income | $-170.1M |
| Net income | $-209.5M |
| Free cash flow | $-137.5M |
| Operating margin | -550.3% |
| Net margin | -677.6% |
| Return on equity | -366.2% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-04
From latest 10-K · 2026-03-04
- Sbc Revenue High
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Sbc Revenue High — SBC/Revenue 30.4%
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -677.6%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -444.8%
- Cash Runway Low — Cash runway ~1.5 years
- Accumulated Deficit High — Accumulated deficit / equity 2037%
- Rd Intensity High — R&D/Revenue 370.7%
Upcoming earnings
TUE.3NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.43
Est. revenue
29.0M
Documents
FormReporting forFiledFlags
Showing 5 of 132 filings